Nobuhiro Kusuba

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial

M. Hagiwara, T. Nomura, Shiro Tanaka, 2021, JID innovations.

Inhibition of IL‐17–committed T cells in a murine psoriasis model by a vitamin D analogue

T. Dainichi, T. Honda, K. Kabashima, 2017, The Journal of allergy and clinical immunology.

Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin

K. Ishii, M. Kubo, L. Ng, 2014, Nature Immunology.

Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab

T. Dainichi, K. Kabashima, T. Kogame, 2022, European Journal of Dermatology.

Rapid regression of metastatic brain tumours in a melanoma patient after dabrafenib/trametinib therapy

T. Honda, K. Kabashima, A. Otsuka, 2017, European Journal of Dermatology.

Efficacy of intravenous immunoglobulins for the treatment of mucous membrane pemphigoid-like epidermolysis bullosa acquisita

T. Dainichi, K. Kabashima, T. Hashimoto, 2017, European Journal of Dermatology.

Thromboxane A2 facilitates IL-17A production from Vγ4+ γδ T cells and promotes psoriatic dermatitis in mice.

S. Narumiya, T. Dainichi, M. Arita, 2018, The Journal of allergy and clinical immunology.